Last reviewed · How we verify
10RAC+acetylcystein — Competitive Intelligence Brief
marketed
Dendritic cell vaccine with antioxidant adjuvant
Immunology
Small molecule
Live · refreshed every 30 min
Target snapshot
10RAC+acetylcystein (10RAC+acetylcystein) — Buddhist Tzu Chi General Hospital. 10RAC combined with acetylcysteine works through immunotherapy (10RAC) paired with an antioxidant/mucolytic agent to enhance immune response and reduce oxidative stress.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| 10RAC+acetylcystein TARGET | 10RAC+acetylcystein | Buddhist Tzu Chi General Hospital | marketed | Dendritic cell vaccine with antioxidant adjuvant |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Dendritic cell vaccine with antioxidant adjuvant class)
- Buddhist Tzu Chi General Hospital · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- 10RAC+acetylcystein CI watch — RSS
- 10RAC+acetylcystein CI watch — Atom
- 10RAC+acetylcystein CI watch — JSON
- 10RAC+acetylcystein alone — RSS
- Whole Dendritic cell vaccine with antioxidant adjuvant class — RSS
Cite this brief
Drug Landscape (2026). 10RAC+acetylcystein — Competitive Intelligence Brief. https://druglandscape.com/ci/10rac-acetylcystein. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing